Jose Baselga - a A leading specialist in the field of oncology, the author of the most important studies in the field of breast cancer, the President of the European Society of Medical Oncology, head of the Cancer Center at Hospital QUIRON, Head of the Department of Oncology at Harvard and the University of Massachusetts;
- 1982 - graduated from the Faculty of Medicine of the Barcelona Autonomous University.
- 1982 1984 - post-graduate training at the University Hospital Vall de hebronite,
- 1984 - training at the National University of New York.
- 1984 - Fellow of the Memorial Cancer Center at the Hospital Sloan - Kettering (United States, New York),
- 1986 - doctor of the Department Thoracic Medicine at the Hospital Sloan - Kettering (United States, New York )
Experience, professional activity
- 1996 - practice in the A leading clinics of Barcelona
- 1997 - Head of the Oncology center, hematology and radiation therapy in the hospital Vall De Gerbon,
- Lecturer at the medical Faculty of oncological diseases at the Autonomous University of Barcelona.
- From 2010 - present. Bp. - Head of the "Department of them. Jose Baselga "at the Hospital Kieron
- 2010 - n. Bp. - Head of the Department of Oncology and Hematology at the Massachusetts National Hospital
- to 2011 - n. Bp. -. The dean of Oncology department at Harvard University
- 2016 - participation in the Davos forum, where he was together with the Vice-President of the United States, Joe Biden.
- 2015 - Mr. BP. - A permanent White House adviser on health issues.
- 2013 - Mr. .vr. . - Director of the Hospital of Memorial Sloan-Kettering, Department of Oncology is a recognized leader in the field of research and treatment of cancer
- Jose Baselga - the only European doctor - a member of the Study Council cancer cells, methods of diagnosis and treatment of cancer. The remaining members of the board - only its of the American medical union
- More than 600 publications in professional medical and scientific publications, co-author of a dozen scientific papers
- 2010 -.. Research by Dr. Jose Baselga in the field of cancer breast glands were recognized community ERC (European Council for research) as the cutting-edge research of today
- Jose Baselga actively developing therapy EGFR (epidermal growth factor receptor) and HER-2 positive breast cancer (HER-2. - a protein that is responsible for the growth factors, if breast cancer is a positive on this criterion, metostazy grow faster).
- Jose Baselga first revealed the possibility of using the antibody trastuzumab in the treatment of such cancers.
Membership in international health organizations
- AACR (American community on the issue of cancer research)
- Chairman SOLTI (Association of Spanish scientists to study breast cancer)
- LICR (Member of the European community of doctors -.. Oncology at the Institute of cancer research, Ludwig University of diseases).
- ESMO President (European community oncologists).
www.youtube.com/embed/U95X-zX7YWQ "frameborder =" 0 "allowfullscreen =" ">
<span class = "redactor-invisible-space"> <br> </Span> </p>